e-ISSN: Pending
Negative / Null Result ReportOpen accessMedicine· cited by 56

Antibody‐based methods for the measurement of α‐synuclein concentration in human cerebrospinal fluid – method comparison and round robin study

Brit Mollenhauer; Frederick DuBois Bowman; Daniel Drake; Jimmy Duong; Kaj Blennow; Omar M. A. El‐Agnaf; Leslie M. Shaw; Jennifer Masucci · 2018 · Journal of Neurochemistry

WASTE classifies this as Negative / Null Result Report · AI classification, approximate

The study found no significant effect — useful as a negative control or null benchmark for your own design.

Abstract

Abstract α‐Synuclein is the major component of Lewy bodies and a candidate biomarker for neurodegenerative diseases in which Lewy bodies are common, including Parkinson's disease and dementia with Lewy bodies. A large body of literature suggests that these disorders are characterized by reduced concentrations of α‐synuclein in cerebrospinal fluid (CSF), with overlapping concentrations compared to healthy controls and variability across studies. Several reasons can account for this variability, including technical ones, such as inter‐assay and inter‐laboratory variation (reproducibility). We co

Abstract by Brit Mollenhauer; Frederick DuBois Bowman; Daniel Drake; Jimmy Duong; Kaj Blennow; Omar M. A. El‐Agnaf; Leslie M. Shaw; Jennifer Masucci, Journal of Neurochemistry (2018) — licensed CC BY 4.0.

About to run something similar?

Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.

WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.

Metadata source: OpenAlex · DOI 10.1111/jnc.14569